Status:
UNKNOWN
Monitoring Cellular Immunity After Kidney and Liver Transplantation
Lead Sponsor:
Karolinska University Hospital
Collaborating Sponsors:
Uppsala University Hospital
Conditions:
Terminal Kidney Failure
Terminal Liver Failure
Eligibility:
All Genders
18+ years
Brief Summary
After transplantation, if insufficient immunosuppression is achieved, rejection and graft loss follows. If to much immunosuppression is given, the patient suffers risk for infections and malignancies....
Eligibility Criteria
Inclusion
- All patients undergoing kidney or liver transplantation at the Karolinska University Hospital
Exclusion
- Abscence of informed consent
Key Trial Info
Start Date :
March 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2009
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00683748
Start Date
March 1 2007
End Date
March 1 2009
Last Update
February 5 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lars Wennberg
Stockholm, Sweden, 14186